These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 36185037)
21. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883 [TBL] [Abstract][Full Text] [Related]
22. Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats. Wood SK; Verhoeven RE; Savit AZ; Rice KC; Fischbach PS; Woods JH Neuropsychopharmacology; 2006 Dec; 31(12):2580-90. PubMed ID: 16710322 [TBL] [Abstract][Full Text] [Related]
23. Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL/6 mice. Pryce CR; Siegl S; Mayer R; Rahmanzadeh G; McAllister KH Neuropharmacology; 2011; 60(2-3):318-27. PubMed ID: 20868699 [TBL] [Abstract][Full Text] [Related]
24. Colorectal distention induces acute and delayed visceral hypersensitivity: role of peripheral corticotropin-releasing factor and interleukin-1 in rats. Nozu T; Kumei S; Miyagishi S; Takakusaki K; Okumura T J Gastroenterol; 2015 Dec; 50(12):1153-61. PubMed ID: 25808230 [TBL] [Abstract][Full Text] [Related]
25. Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress. Tran L; Chaloner A; Sawalha AH; Greenwood Van-Meerveld B Psychoneuroendocrinology; 2013 Jun; 38(6):898-906. PubMed ID: 23084728 [TBL] [Abstract][Full Text] [Related]
26. Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats. Martínez V; Taché Y Brain Res; 2001 Mar; 893(1-2):29-35. PubMed ID: 11222989 [TBL] [Abstract][Full Text] [Related]
27. Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor. Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T J Gastroenterol Hepatol; 2017 Dec; 32(12):1958-1965. PubMed ID: 28299830 [TBL] [Abstract][Full Text] [Related]
28. Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat. Johnson AC; Tran L; Schulkin J; Greenwood-Van Meerveld B Neurogastroenterol Motil; 2012 May; 24(5):479-86, e219. PubMed ID: 22364507 [TBL] [Abstract][Full Text] [Related]
29. Water avoidance stress induces visceral hyposensitivity through peripheral corticotropin releasing factor receptor type 2 and central dopamine D2 receptor in rats. Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T Neurogastroenterol Motil; 2016 Apr; 28(4):522-31. PubMed ID: 26662216 [TBL] [Abstract][Full Text] [Related]
30. Opposing Roles of Estradiol and Testosterone on Stress-Induced Visceral Hypersensitivity in Rats. Ji Y; Hu B; Li J; Traub RJ J Pain; 2018 Jul; 19(7):764-776. PubMed ID: 29496640 [TBL] [Abstract][Full Text] [Related]
32. CRF receptor antagonist astressin-B reverses and prevents alopecia in CRF over-expressing mice. Wang L; Million M; Rivier J; Rivier C; Craft N; Stenzel-Poore MP; Taché Y PLoS One; 2011 Feb; 6(2):e16377. PubMed ID: 21359208 [TBL] [Abstract][Full Text] [Related]
33. CRF-R1 activation in the anterior-dorsal BNST induces maternal neglect in lactating rats via an HPA axis-independent central mechanism. Klampfl SM; Brunton PJ; Bayerl DS; Bosch OJ Psychoneuroendocrinology; 2016 Feb; 64():89-98. PubMed ID: 26630389 [TBL] [Abstract][Full Text] [Related]
34. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Stengel A; Goebel M; Wang L; Rivier J; Kobelt P; Mönnikes H; Lambrecht NW; Taché Y Endocrinology; 2009 Nov; 150(11):4911-9. PubMed ID: 19797401 [TBL] [Abstract][Full Text] [Related]
35. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin. Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626 [TBL] [Abstract][Full Text] [Related]
36. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Martinez V; Taché Y Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612 [TBL] [Abstract][Full Text] [Related]
37. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Bravo JA; Dinan TG; Cryan JF Int J Neuropsychopharmacol; 2011 Jun; 14(5):666-83. PubMed ID: 20860876 [TBL] [Abstract][Full Text] [Related]
38. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582 [TBL] [Abstract][Full Text] [Related]
39. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Nakade Y; Fukuda H; Iwa M; Tsukamoto K; Yanagi H; Yamamura T; Mantyh C; Pappas TN; Takahashi T Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1037-44. PubMed ID: 17158256 [TBL] [Abstract][Full Text] [Related]
40. Peripheral corticotropin-releasing factor (CRF) induces stimulation of gastric contractions in freely moving conscious rats: role of CRF receptor types 1 and 2. Nozu T; Tsuchiya Y; Kumei S; Takakusaki K; Okumura T Neurogastroenterol Motil; 2013 Feb; 25(2):190-7. PubMed ID: 23205497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]